サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1482411

レンチウイルスベクター市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、2024年～2032年予測

Lentiviral Vectors Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 234 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.78円
レンチウイルスベクター市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、2024年～2032年予測
出版日: 2024年05月14日
発行: Persistence Market Research
ページ情報: 英文 234 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界のレンチウイルスベクター市場に関する詳細な調査を発表し、重要な市場力学、成長触媒、課題、新興動向に関する包括的な洞察を提供しました。この調査レポートは、レンチウイルスベクター市場に関する貴重な展望を提供し、2024年から2032年までの市場の軌跡を予測する独自のデータと統計を提示しています。

レンチウイルスベクター市場の2024年から2032年までのCAGRは11.4%で、2024年の市場規模は1億5,830万米ドル、2032年には4億1,120万米ドルに成長すると予測されます。

主な洞察

  • レンチウイルスベクター市場のCAGR（2024～2032年）：11.4%
  • レンチウイルスベクター市場規模（2024年）：1億5,830万米ドル
  • レンチウイルスベクターの市場規模（2032年）：4億1,120万米ドル

調査範囲：

本レポートでは、世界中の遺伝子治療およびバイオテクノロジー分野でレンチウイルスベクターの採用を推進している様々な用途や技術的進歩について掘り下げています。市場促進要因、市場抑制要因、市場情勢を形成する機会などの市場ダイナミクスを評価しています。さらに、競合情報や主要市場企業が採用する事業戦略に関する戦略的考察も提供しています。

市場促進要因：

レンチウイルスベクター市場は、遺伝性疾患の有病率の増加、遺伝子治療研究の進歩、効果的な治療方法に対する需要の高まりなどの要因によって牽引されています。さらに、バイオテクノロジーセクターの拡大と研究開発イニシアティブへの投資の増加が市場成長をさらに後押しします。

市場抑制要因：

有望な成長見通しにもかかわらず、レンチウイルスベクター市場には課題が存在します。これには、遺伝子治療製品に関連する規制上のハードル、ウイルスベクターに関連する安全性の懸念、大規模ベクター生産の複雑さなどが含まれます。さらに、高い治療費と限られたアクセシビリティが市場拡大の妨げとなっています。

市場機会：

レンチウイルスベクター市場には、技術革新と市場浸透のための有利な機会があります。ベクター設計と製造技術の継続的な進歩は、希少疾患やがん治療における用途の拡大と相まって、市場企業に有望な道を提供しています。さらに、製品開発と商業化のための戦略的提携やパートナーシップは、市場の将来性を高めています。

本レポートで扱う主な質問

  • レンチウイルスベクター市場の成長を促進する主な要因は何か？
  • 技術の進歩はレンチウイルスベクター市場の競合情勢をどのように変えているか？
  • レンチウイルスベクターの世界市場で予想される主な市場動向と将来展望は？
  • レンチウイルスベクター市場のリーディング企業は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • アプリケーションイノベーション/開発動向

第4章 重要成功要因

  • 製品採用分析
  • 主な規制
  • メーカーの主なプロモーション戦略
  • PESTLE分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19の現在の統計と今後の影響の可能性
  • 現在のGDP予測と予想される影響
  • COVID-19と影響分析
    • 製品別
    • 適応症別
    • エンドユーザー別
  • 2024年の市場シナリオ

第7章 世界のレンチウイルスベクター市場の需要価値分析

  • 過去の市場価値分析（2019年～2023年）
  • 現在および将来の市場価値予測（2024年～2032年）
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 レンチウイルスベクターの世界市場分析：製品別

  • イントロダクション/主な調査結果
  • 過去の市場価値：製品別（2019年～2023年）
  • 現在および将来の市場価値分析と予測：製品別（2024年～2032年）
    • キット
      • レンチウイルスパッキングシステム
      • レンチウイルス発現システム
      • レンチウイルスプロモーターキット
      • レンチウイルス融合タグ
    • 試薬・消耗品
  • 製品別の市場魅力度分析

第9章 レンチウイルスベクターの世界市場分析：適応症別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析：適応症別（2019年～2023年）
  • 現在および将来の市場規模分析と予測：適応症別（2024年～2032年）
    • がん
    • 遺伝性疾患
    • 感染症
    • 獣医疾患
    • その他
  • 適応症別の魅力分析

第10章 レンチウイルスベクターの世界市場分析：エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析：エンドユーザー別（2019年～2023年）
  • 現在および将来の市場規模分析と予測：エンドユーザー別（2024年～2032年）
    • バイオテクノロジー企業
    • 製薬会社
    • 受託研究機関
    • 学術調査機関
  • エンドユーザー別の市場魅力度分析

第11章 レンチウイルスベクター市場分析：地域別

  • イントロダクション
  • 過去の市場規模分析：地域別（2019年～2023年）
  • 現在の市場規模分析と予測：地域別（2024年～2032年）
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 地域別の市場魅力度分析

第12章 北米のレンチウイルスベクター市場分析

第13章 ラテンアメリカのレンチウイルスベクター市場分析

第14章 欧州のレンチウイルスベクター市場分析

第15章 南アジアのレンチウイルスベクター市場分析

第16章 東アジアのレンチウイルスベクター市場分析

第17章 オセアニアのレンチウイルスベクター市場分析

第18章 中東・アフリカのレンチウイルスベクター市場分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Thermo Fisher Scientific
    • PerkinElimer Inc.
    • GENEMEDI
    • Takara Bio Inc.
    • Sino Biological Inc.
    • OriGene Technologies, Inc.
    • Charles River Laboratories
    • Cell Biolabs, Inc.
    • Applied Biological Materials Inc.

第20章 前提と頭字語

第21章 調査手法

目次
Product Code: PMRREP33074

Persistence Market Research has recently unveiled a detailed examination of the global Lentiviral Vectors Market, providing a comprehensive insight into the crucial market dynamics, growth catalysts, challenges, and emerging trends. This report furnishes invaluable perspectives into the Lentiviral Vectors Market, presenting exclusive data and statistics projecting the market's trajectory from 2024 to 2032.

The CAGR for the Lentiviral Vectors Market from 2024 to 2032 is 11.4%, with a market size of US$ 158.3 million in 2024 and projected to grow to US$ 411.2 million by 2032.

Key Insights:

  • Lentiviral Vectors Market CAGR (2024-2032): 11.4%
  • Lentiviral Vectors Market Size (2024): US$ 158.3 Million
  • Lentiviral Vectors Market Size (2032): US$ 411.2 Million

Report Scope:

This report dives into various applications and technological advancements propelling the adoption of lentiviral vectors in gene therapy and biotechnology sectors worldwide. It evaluates market dynamics, including drivers, restraints, and opportunities shaping the market landscape. Additionally, it offers strategic insights into competitive intelligence and business strategies adopted by key market players.

Market Growth Drivers:

The Lentiviral Vectors Market is driven by factors such as the increasing prevalence of genetic disorders, advancements in gene therapy research, and the growing demand for effective treatment modalities. Moreover, the expanding biotechnology sector and rising investments in R&D initiatives further fuel market growth.

Market Restraints:

Despite promising growth prospects, challenges exist in the Lentiviral Vectors Market. These include regulatory hurdles associated with gene therapy products, safety concerns related to viral vectors, and complexities in large-scale vector production. Additionally, high treatment costs and limited accessibility hinder market expansion.

Market Opportunities:

The Lentiviral Vectors Market presents lucrative opportunities for innovation and market penetration. Continued advancements in vector design and manufacturing technologies, coupled with expanding applications in rare diseases and cancer therapy, offer promising avenues for market players. Moreover, strategic collaborations and partnerships for product development and commercialization enhance market prospects.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Lentiviral Vectors Market?
  • How are technological advancements reshaping the competitive landscape of the Lentiviral Vectors Market?
  • What are the key market trends and future prospects anticipated in the global Lentiviral Vectors Market?
  • Who are the leading players in the Lentiviral Vectors Market?

Competitive Intelligence and Business Strategy:

The Lentiviral Vectors Market is characterized by intense competition, with key players such as Thermo Fisher Scientific, Merck KGaA, and SIRION Biotech GmbH dominating. Thermo Fisher Scientific is renowned for its comprehensive lentiviral vector platforms tailored to research and clinical applications. Merck KGaA leverages its expertise in bioprocessing and gene editing technologies, while SIRION Biotech GmbH focuses on custom vector design services. Emerging players like OriGene Technologies and GenScript Biotech Corporation concentrate on niche markets, such as lentiviral-based gene delivery systems and viral vector manufacturing services. Each competitor brings unique strengths and technological capabilities to the table, driving innovation and shaping the dynamic landscape of the Lentiviral Vectors industry.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • PerkinElimer Inc.
  • GENEMEDI
  • Takara Bio Inc.
  • Sino Biological Inc.
  • OriGene Technologies, Inc.
  • Charles River Laboratories
  • Cell Biolabs, Inc.
  • Applied Biological Materials Inc.

Lentiviral Vectors Market Segmentation:

Lentiviral Vectors Market by Product:

  • Lentiviral Vector Kits

Lentiviral Packing Systems

Lentiviral Expression Systems

Lentiviral Promoter Kits

Lentiviral Fusion Tags

  • Reagents & Consumables

Lentiviral Vectors Market by Indication:

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Veterinary Diseases
  • Others

Lentiviral Vectors Market by End User:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes

Lentiviral Vectors Market by Region:

  • North America Lentiviral Vectors Market
  • Latin America Lentiviral Vectors Market
  • Europe Lentiviral Vectors Market
  • South Asia Lentiviral Vectors Market
  • East Asia Lentiviral Vectors Market
  • Oceania Lentiviral Vectors Market
  • Middle East & Africa Lentiviral Vectors Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Application Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Key Regulations
  • 4.3. Key Promotional Strategies by Manufacturers
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Per-Capita Healthcare Expenditure
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. COVID-19 Pandemic
    • 5.2.2. Increasing Prevalence of Cancer
    • 5.2.3. Rise in R&D Investments
    • 5.2.4. Top Lentiviral Vectors Companies and Their Historical Growth
    • 5.2.5. Rise in Number of Clinical Studies
    • 5.2.6. Increasing Investment in Lentiviral Vectors Research
    • 5.2.7. GDP Growth
    • 5.2.8. Adoption Rate of Lentiviral Vectors Products
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. Current COVID-19 Statistics and Probable Future Impact
  • 6.2. Current GDP Projection and Probable Impact
  • 6.3. COVID-19 and Impact Analysis
    • 6.3.1. By Product
    • 6.3.2. By Indication
    • 6.3.3. By End User
  • 6.4. 2024 Market Scenario

7. Global Lentiviral Vectors Market Demand Value (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Value (US$ Mn) By Product, 2019-2023
  • 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 8.3.1. Kits
      • 8.3.1.1. Lentiviral Packing System
      • 8.3.1.2. Lentiviral Expression System
      • 8.3.1.3. Lentiviral Promoter Kit
      • 8.3.1.4. Lentiviral Fusion Tags
    • 8.3.2. Reagents & Consumables
  • 8.4. Market Attractiveness Analysis By Product

9. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Indication, 2024-2032
    • 9.3.1. Cancer
    • 9.3.2. Genetic Disorder
    • 9.3.3. Infectious Disease
    • 9.3.4. Veterinary Disease
    • 9.3.5. Others
  • 9.4. Attractiveness Analysis By Indication

10. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
    • 10.3.1. Biotechnology Companies
    • 10.3.2. Pharmaceutical Companies
    • 10.3.3. Contract Research Organization (CRO)
    • 10.3.4. Academic and Research Institutes
  • 10.4. Market Attractiveness Analysis By End User

11. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Value (US$ Mn) Analysis By Region, 2019-2023
  • 11.3. Current Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Indication
    • 12.4.4. By End User
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Lentiviral Vectors Market
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.1.2.1. By Product
        • 12.7.1.2.2. By Indication
        • 12.7.1.2.3. By End User
    • 12.7.2. Canada Lentiviral Vectors Market
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.7.2.2.1. By Product
        • 12.7.2.2.2. By Indication
        • 12.7.2.2.3. By End User

13. Latin America Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By End User
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Brazil Lentiviral Vectors Market
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.1.2.1. By Product
        • 13.7.1.2.2. By Indication
        • 13.7.1.2.3. By End User
    • 13.7.2. Mexico Lentiviral Vectors Market
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.2.2.1. By Product
        • 13.7.2.2.2. By Indication
        • 13.7.2.2.3. By End User
    • 13.7.3. Argentina Lentiviral Vectors Market
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.7.3.2.1. By Product
        • 13.7.3.2.2. By Indication
        • 13.7.3.2.3. By End User

14. Europe Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Lentiviral Vectors Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Indication
        • 14.7.1.2.3. By End User
    • 14.7.2. Italy Lentiviral Vectors Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Indication
        • 14.7.2.2.3. By End User
    • 14.7.3. France Lentiviral Vectors Market
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.3.2.1. By Product
        • 14.7.3.2.2. By Indication
        • 14.7.3.2.3. By End User
    • 14.7.4. U.K. Lentiviral Vectors Market
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.4.2.1. By Product
        • 14.7.4.2.2. By Indication
        • 14.7.4.2.3. By End User
    • 14.7.5. Spain Lentiviral Vectors Market
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.5.2.1. By Product
        • 14.7.5.2.2. By Indication
        • 14.7.5.2.3. By End User
    • 14.7.6. BENELUX Union Lentiviral Vectors Market
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.6.2.1. By Product
        • 14.7.6.2.2. By Indication
        • 14.7.6.2.3. By End User
    • 14.7.7. Russia Lentiviral Vectors Market
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.7.2.1. By Product
        • 14.7.7.2.2. By Indication
        • 14.7.7.2.3. By End User

15. South Asia Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By End User
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. India Lentiviral Vectors Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Indication
        • 15.7.1.2.3. By End User
    • 15.7.2. Indonesia Lentiviral Vectors Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Indication
        • 15.7.2.2.3. By End User
    • 15.7.3. Malaysia Lentiviral Vectors Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Indication
        • 15.7.3.2.3. By End User
    • 15.7.4. Thailand Lentiviral Vectors Market
      • 15.7.4.1. Introduction
      • 15.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.4.2.1. By Product
        • 15.7.4.2.2. By Indication
        • 15.7.4.2.3. By End User

16. East Asia Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. China Lentiviral Vectors Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Indication
        • 16.7.1.2.3. By End User
    • 16.7.2. Japan Lentiviral Vectors Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Indication
        • 16.7.2.2.3. By End User
    • 16.7.3. South Korea Lentiviral Vectors Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Indication
        • 16.7.3.2.3. By End User

17. Oceania Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Lentiviral Vectors Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Indication
        • 17.7.1.2.3. By End User
    • 17.7.2. New Zealand Lentiviral Vectors Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Indication
        • 17.7.2.2.3. By End User

18. Middle East and Africa (MEA) Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By End User
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Lentiviral Vectors Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Indication
        • 18.7.1.2.3. By End User
    • 18.7.2. Turkey Lentiviral Vectors Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Indication
        • 18.7.2.2.3. By End User
    • 18.7.3. South Africa Lentiviral Vectors Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Indication
        • 18.7.3.2.3. By End User

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Thermo Fisher Scientific
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. Strategy Overview
        • 19.3.1.5.1. Marketing Strategy
        • 19.3.1.5.2. Drug type Strategy
        • 19.3.1.5.3. Channel Strategy
    • 19.3.2. PerkinElimer Inc.
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.2.4. Sales Footprint
      • 19.3.2.5. Strategy Overview
        • 19.3.2.5.1. Marketing Strategy
        • 19.3.2.5.2. Drug type Strategy
        • 19.3.2.5.3. Channel Strategy
    • 19.3.3. GENEMEDI
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.3.4. Sales Footprint
      • 19.3.3.5. Strategy Overview
        • 19.3.3.5.1. Marketing Strategy
        • 19.3.3.5.2. Drug type Strategy
        • 19.3.3.5.3. Channel Strategy
    • 19.3.4. Takara Bio Inc.
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.4.4. Sales Footprint
      • 19.3.4.5. Strategy Overview
        • 19.3.4.5.1. Marketing Strategy
        • 19.3.4.5.2. Drug type Strategy
        • 19.3.4.5.3. Channel Strategy
    • 19.3.5. Sino Biological Inc.
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.5.4. Sales Footprint
      • 19.3.5.5. Strategy Overview
        • 19.3.5.5.1. Marketing Strategy
        • 19.3.5.5.2. Drug type Strategy
        • 19.3.5.5.3. Channel Strategy
    • 19.3.6. OriGene Technologies, Inc.
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.6.4. Sales Footprint
      • 19.3.6.5. Strategy Overview
        • 19.3.6.5.1. Marketing Strategy
        • 19.3.6.5.2. Drug type Strategy
        • 19.3.6.5.3. Channel Strategy
    • 19.3.7. Charles River Laboratories
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.7.4. Sales Footprint
      • 19.3.7.5. Strategy Overview
        • 19.3.7.5.1. Marketing Strategy
        • 19.3.7.5.2. Drug type Strategy
        • 19.3.7.5.3. Channel Strategy
    • 19.3.8. Cell Biolabs, Inc.
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.8.4. Sales Footprint
      • 19.3.8.5. Strategy Overview
        • 19.3.8.5.1. Marketing Strategy
        • 19.3.8.5.2. Drug type Strategy
        • 19.3.8.5.3. Channel Strategy
    • 19.3.9. Applied Biological Materials Inc.
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Profitability by Market Segments (Drug type/Channel/Region)
      • 19.3.9.4. Sales Footprint
      • 19.3.9.5. Strategy Overview
        • 19.3.9.5.1. Marketing Strategy
        • 19.3.9.5.2. Drug type Strategy
        • 19.3.9.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology